FDA Label for Puregen Labs Pain Relief 4 Lidocaine
View Indications, Usage & Precautions
Puregen Labs Pain Relief 4 Lidocaine Product Label
The following document was submitted to the FDA by the labeler of this product Advanced Rx Llc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Drug Facts
Active Ingredient
Lidocaine 4.00 %
Purpose
Topical Anesthetic
Uses:
- For the temporary relief of pain.
Warnings:
For external use only.
Do Not Use
- more than 1 patch at a time
- on wounds or damaged skin
- with a heating pad
- If you are allergic to any ingredients of this product
When Using This Product
- Avoid contact with the eyes
Stop Use And Ask A Doctor If
- localized skin reactions occur, such as rash, itching, redness, irritation
- condition worsens, or if
- symptoms persist for more than 7 days or clear up and occur again within a few days.
Keep Out Of Reach Of Children.
If swallowed, get medical help, or contact a Poison Control Center right away.
If Pregnant Or Breast-Feeding,
ask a health professional before use
Directions:
- Adults andchildren 12 years of age and older:
- Clean and dry the affected area
- Apply a patch at a time to the affected area; not more than 3 or 4 times daily to the affected area
- Remove the patch from the skin after at most 8 hours of application
- Children under 12 years of age: consult a doctor.
Other Information:
- Store at 20-25°C (68-77°F) and protect from moisture.
Inactive Ingredients
Aqua (Deionized Water), Dihydroxyaluminum Aminoacetate, Disodium EDTA, Glycerin, Methylparaben, Polyvinyl Alcohol, Propylene Glycol, Propylparaben, Sodium Carboxymethyl Cellulose, Sodium Polyacrylate, Tartaric Acid, Titanium Dioxide
Questions?
call toll-free 1-800-630-8895
Package Labeling:
* Please review the disclaimer below.